<DOC>
	<DOCNO>NCT01371071</DOCNO>
	<brief_summary>A majority patient multiple sclerosis initially present single demyelinate event , e.g . optic nerve , brain , brainstem spinal cord , refer clinically isolated syndrome ( CIS ) . Not patient CIS get relapse develop multiple sclerosis patient , irreversible damage central nervous system , e.g . axonal damage , already detectable early stage disease . Early initiation immunomodulatory therapy crucial patient clinically isolated syndrome high risk development multiple sclerosis . Vice versa identification low risk patient could help avoid unnecessary therapy . In prospective observational study want follow patient CIS early multiple sclerosis period four year obtain clinical , laboratory MRI - data order identify risk factor relapse , prognostic factor therapy response marker .</brief_summary>
	<brief_title>Cohort Study Clinically Isolated Syndrome Early Multiple Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>age &gt; 18 year sign informed consent clinically isolated syndrome within last 6 month diagnosis multiple sclerosis within last two year eye disease could interfere OCT ( e.g . glaucoma , diabetic retinopathy ) secondary progressive multiple sclerosis pregnancy contraindication MRI , e.g . pacemaker , metal implant , allergy gadolinium alcohol drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Clinically isolated syndrome ( CIS )</keyword>
	<keyword>Multiple sclerosis ( MS )</keyword>
	<keyword>Immunomodulatory therapy</keyword>
	<keyword>Prognostic marker</keyword>
	<keyword>MRI</keyword>
	<keyword>OCT</keyword>
</DOC>